Meta-analysis of statins in chronic kidney disease: who benefits?
about
Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort).Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms.The coronary artery calcification score and common iliac artery calcification score in non-dialysis CKD patients.
P2860
Meta-analysis of statins in chronic kidney disease: who benefits?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Meta-analysis of statins in chronic kidney disease: who benefits?
@en
type
label
Meta-analysis of statins in chronic kidney disease: who benefits?
@en
prefLabel
Meta-analysis of statins in chronic kidney disease: who benefits?
@en
P2860
P356
P1476
Meta-analysis of statins in chronic kidney disease: who benefits?
@en
P2093
P2860
P356
10.1093/QJMED/HCX040
P407
P577
2017-03-14T00:00:00Z